On further evaluation, the relationship between COX‐2 expression and the clinical characteristics of patients with osteosarcoma showed no significant correlation of COX‐2 expression with age, gender, tumor location, cancer histology, and necrosis across each study (Figs 10 and 11). This evidence concerns the gene PTGS2 and cancer.